Principal Investigator (PI)
The Barcelona Centre for International Health Research (CRESIB)
The Foundation is providing £266,850 in support.
Richard Thomson - Nuria Antón - Mireia Ferrer
GSK has a group working on the P.vivax culture and the CRESIB and GSK scientists will work in close collaboration. This project will require work in the GSK Biosafety level 3 facilities at Tres Cantos.
This two-year project is focused on creating a continuous lab-based supply of the P. vivax malaria parasite in the blood stage. If successful this project will offer a technological breakthrough that could facilitate further advances in research on P. vivax and potentially lead to a new era in P.vivax malaria drug discovery.